New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S952

Introduced
1/31/22  

Caption

Requires persons picking up prescriptions for Schedule II controlled dangerous substances to present identification.

Impact

If enacted, S952 will amend existing laws by embedding stricter controls on the dispensation of Schedule II CDS. It seeks to provide law enforcement and health officials with improved means to track prescription patterns and identify misuse or illegal distribution of these substances. The bill's requirement for logbooks will ensure that pharmacists maintain accurate records and can aid in investigations related to drug recalls or law enforcement inquiries.

Summary

Senate Bill S952 aims to control the dispensing of Schedule II controlled dangerous substances (CDS) by mandating that individuals authorized to possess such substances present valid photographic identification before their prescriptions are filled. The bill also requires the pharmacist to maintain a logbook where the individual's name, address, and the date and time of dispensation are recorded. This action aims to enhance safety and accountability in the handling of potentially dangerous medications, as these substances have a high potential for abuse and dependence.

Contention

Notable points of contention include the implications of such strict identification requirements on patients, particularly those who may lack proper documentation or are vulnerable populations. Critics argue that while the intention is to curtail abuse, it may inadvertently restrict access to necessary medications for legitimate patients. Supporters assert that the bill is a necessary step towards monitoring and mitigating the opioid crisis, while opponents caution against potential barriers to patients in need of pain management.

Additional_info

The bill also includes a provision that ensures logbook information is protected from public disclosure except in cases necessary for public health safety or law enforcement. This aims to balance the need for tracking prescription drugs against individual privacy rights.

Companion Bills

No companion bills found.

Previously Filed As

NJ A4957

Authorizes prescription of Schedule II controlled dangerous substances through telemedicine or telehealth without certain in-person requirements.

NJ HB3767

Controlled dangerous substances; adding certain substances to Schedules I and IV; effective date.

NJ A4852

Permits prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.

NJ S1865

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ A4494

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ S322

Establishes tianeptine as Schedule II controlled dangerous substance.

NJ SB27

Controlled dangerous substances; exempting certain practitioners from electronic prescription requirement. Effective date.

NJ SB27

Controlled dangerous substances; exempting certain practitioners from electronic prescription requirement. Effective date.

NJ HB417

Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine

NJ HB0417

Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine

Similar Bills

NJ A3359

Regulates provision of pharmaceutical services in nursing homes.

NJ S2990

Regulates provision of pharmaceutical services in long-term care facilities.

CA AB1366

Reimbursement for pharmacist services.

CA AB2571

Reimbursement for pharmacist services.

HI SB1245

Relating To Pharmacists.

TX HB3540

Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.

HI SB324

Relating To Pharmacists.

HI SB324

Relating To Pharmacists.